InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Kurtz Ronald M MD, Autre. Director active across 1 company, notably RxSight, Inc.. Aggregated, 8 disclosures have been recorded. Split: 1 buy · 4 sells. Total volume traded: €6.7m. History available since 3 August 2021. The latest transaction was filed on 9 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Kurtz Ronald M MD is a declarant linked to RxSight, Inc. (XNAS), where he holds the role of President & CEO. Across 8 filings recorded, the sampled recent filings cover the period from 2021-08-05 to 2024-08-09, with buys of eur 1685000 and sells of eur 5056080, and the modal transaction nature is Sale.